<DOC>
	<DOCNO>NCT02902575</DOCNO>
	<brief_summary>The purpose study explore safety , feasibility , long-term oncologicaloutcomes laparoscopic-assisted gastrectomy advance Gastric Cancer neoadjuvant chemotherapy .</brief_summary>
	<brief_title>The Safety Feasibility Laparoscopic-assisted Gastrectomy Advanced Gastric Cancer After Neoadjuvant Chemotherapy</brief_title>
	<detailed_description>A prospective single-arm study design evaluate laparoscopic-assisted gastrectomy advance Gastric Cancer neoadjuvant chemotherapy perform , evaluate safety , feasibility , long-term oncological outcome . The evaluation parameter perioperative mobility mortality , perioperative clinical efficacy , postoperative life quality , immune function 3-year survival recurrence rate .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Age 18 75 year Primary gastric adenocarcinoma ( papillary , tubular , mucinous , signet ring cell , poorly differentiate ) confirm pathologically endoscopic biopsy cT4N+M0 preoperative evaluation accord American Joint Committee Cancer ( AJCC ) Cancer Staging Manual Seventh Edition No distant metastasis observe . And spleen , pancreas adjacent organ involve tumor . Performance status 0 1 Eastern Cooperative Oncology Group scale ( ECOG ) American Society Anesthesiology score ( ASA ) class I , II , III Written inform consent Women pregnancy breastfeed Severe mental disorder History previous upper abdominal surgery ( except laparoscopic cholecystectomy , previous gastrectomy , endoscopic mucosal resection endoscopic submucosal dissection ) History previous gastrectomy , endoscopic mucosal resection endoscopic submucosal dissection History malignant disease within past five year History unstable angina myocardial infarction within past six month History cerebrovascular accident within past six month History continuous systematic administration corticosteroid within one month Requirement simultaneous surgery disease Emergency surgery due complication ( bleeding , obstruction perforation ) cause gastric cancer FEV1ï¼œ50 % predict value</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Stomach Neoplasms</keyword>
	<keyword>Laparoscopy</keyword>
	<keyword>Advanced Gastric Cancer</keyword>
	<keyword>Neoadjuvant Chemotherapy</keyword>
</DOC>